 | | | | The U.S. Department of Health and Human Services (HHS) on Tuesday said it will significantly expand the number of distribution locations for monkeypox vaccines and treatments through a new $20 million contract with AmerisourceBergen Corp. | | | | | | New COVID-19 boosters aimed at fighting currently circulating variants of the coronavirus will be widely available this week, U.S. health officials said on Tuesday, adding that the vaccine is moving closer to an annual jab, as with flu shots. | | | | | | CVS Health Corp said on Tuesday it expects "meaningful" tax benefits from its $8 billion purchase of home healthcare services company Signify Health . | | | | | | EU officials on Tuesday recommended that the two Omicron- tailored vaccines recently endorsed by the European Medicines Agency (EMA) be first deployed in high-risk individuals. | | | | | | U.S. life sciences firm Illumina will have to divest biotechnology company Grail after an EU veto of the $7.1 billion acquisition over concerns it would hurt competition and stifle innovation. | | | | | | Bharat Biotech's COVID-19 recombinant nasal vaccine has been approved by the Indian drug regulator, the country's health minister Mansukh Mandaviya tweeted on Tuesday. | | | | | | Hong Kong has reported its first case of monkeypox, health authorities said on Tuesday, after symptoms were discovered in a 30-year old man who arrived from the Phillippines after travelling in the United States and Canada. | | | | | | CVS Health Corp on Monday agreed to buy home healthcare services company Signify Health for about $8 billion in cash, a move that will enable one of the largest U.S. healthcare companies to provide further care management to patients in their homes. | | | | | | New infections with monkeypox are steadily declining in Spain, which has recorded the world's second-highest tally of cases in this year's global outbreak, Health Minister Carolina Darias said on Monday. | | | | | | The European Union's drugs regulator may be a few weeks from deciding whether to approve the experimental COVID-19 vaccine developed by French drugmaker Sanofi and its British partner GSK , a Sanofi executive said on Monday. | | | | | |
